Publications

Evaluating clinical decision rules and rapid diagnostic tests for the diagnosis of Streptococcus pyogenes pharyngitis in Gambian children: A diagnostic accuracy study.

Armitage, EP; Senghore, E; Camara, FE; JARJU, S; Jagne, S; Ceesay, E; Darboe, FF; De Crombrugghe, G; KEELEY, AJ; Hall, JN; Angyal, A; Jammeh, M; DARBOE, S; KUCHARSKI, A; Smeesters, PR; De Silva, TI; MARKS, M; MRCG StrepA Study Group,;

2025

Journal of Infection, (2025).91 2 10.1016/j.jinf.2025.106546.

Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials.

WHITE, RG; Churchyard, GJ; HORTON, KC; Fiore-Gartland, A; Behr, MA; CLARK, RA; Cobelens, F; Ernst, JD; Esmail, H; Garcia-Basteiro, AL; Hadinegoro, SR; Hanekom, WA; Hatherill, M; Hill, PC; Muloiwa, R; Pelzer, PT; Rangaka, L; Rees, H; Schrager, L; Stanley, M; Tufet, M; Wong, EB; HOUBEN, RM G J;

2025

The Lancet. Respiratory medicine, (2025).13 10 10.1016/S2213-2600(25)00164-X.

Flexible Distributed Lag Models for Count Data Using mgcv.

Economou, T; Parliari, D; Tobias, A; Dawkins, L; Steptoe, H; Sarran, C; Stoner, O; LOWE, R; Lelieveld, J;

2025

The American statistician, (2025).79 3 10.1080/00031305.2025.2505514.

NaomiWaterlow/Future_projections_AMR.

KNIGHT, GM; Waterlow, N;

2025

, Zenodo (2025).

The delivery of new tuberculosis vaccines to people living with HIV - when to vaccinate?.

SUMNER, T; CLARK, RA; PRYS-JONES, TO; Bakker, R; Churchyard, G; WHITE, RG;

2025

BMC Infectious Diseases, (2025).25 1 10.1186/s12879-025-11249-y.

How to incorporate social vulnerability into epidemic mathematical modelling: recommendations from an international Delphi.

Naidoo, M; Shephard, W; Mtshali, N; Kambewe, I; Muthien, B; Abuelezam, NN; Ponce-de-Leon, M; Villela, DA M; Paes-Sousa, R; Pan-Ngum, W; Dowdy, D; Morse, SS; Pena, D; Barberia, LG; HOUBEN, RM G J; Arcos González, P; Robertson, JE; Muleia, R; Lawal, O; Rasella, D;

2025

Social Science & Medicine, (2025).383, 10.1016/j.socscimed.2025.118352.

The potential global health impact and cost-effectiveness of next-generation influenza vaccines: A modelling analysis.

GOODFELLOW, L; PROCTER, SR; Koltai, M; Waterlow, NR; FILIPE, JA N; WONG, CK H; VAN LEEUWEN, E; EGGO, RM; Jit, M; WHO Technical Advisory Group for the Full Value of,; Next-generation influenza vaccine impact modelling,;

2025

PLoS medicine, (2025).22 6 10.1371/journal.pmed.1004655.

The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research?.

Andrews, JR; Charalambous, S; Churchyard, G; Cobelens, F; Fernández-Escobar, C; Frick, M; Hanekom, W; Hatherill, M; Hill, PC; Pandey, S; Rangaka, MX; WHITE, RG; Lemos, EF; Da Silva, AM; Croda, J; Garcia-Basteiro, AL;

2025

The Lancet. Infectious diseases, (2025).25 12 10.1016/s1473-3099(25)00305-6.

Modelling the effect of a nutritional shock on tuberculosis in India.

CLARK, RA; Bakker, R; Alexander, P; Henry, R; WHITE, RG; Sinha, P; HOUBEN, RM G J; MCQUAID, CF;

2025

BMC global and public health, (2025).3 1 10.1186/s44263-025-00153-x.

Estimating the basic reproduction number of measles in low- and middle-income settings using 172 serostudies: a modelling approach.

FU, H; Sbarra, AN; Russell, T; Abbas, K; Auzenbergs, M; Jit, M;

2025

F1000 Research Ltd (2025). 10.12688/verixiv.1186.1.